119 related articles for article (PubMed ID: 11206036)
1. Methadone maintenance treatment: is it possible to adapt the daily doses to the metabolic activity of the patient?
Charlier C; Dessalles MC; Plomteux G
Ther Drug Monit; 2001 Feb; 23(1):1-3. PubMed ID: 11206036
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P4503A4 metabolic activity, methadone blood concentrations, and methadone doses.
Shinderman M; Maxwell S; Brawand-Amey M; Golay KP; Baumann P; Eap CB
Drug Alcohol Depend; 2003 Mar; 69(2):205-11. PubMed ID: 12609702
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic drug monitoring in methadone maintenance: choosing a matrix.
Moolchan ET; Umbricht A; Epstein D
J Addict Dis; 2001; 20(2):55-73. PubMed ID: 11318398
[TBL] [Abstract][Full Text] [Related]
4. A single dose of methadone inhibits cytochrome P-4503A activity in healthy volunteers as assessed by the urinary cortisol ratio.
Boulton DW; Arnaud P; DeVane CL
Br J Clin Pharmacol; 2001 Apr; 51(4):350-4. PubMed ID: 11318772
[TBL] [Abstract][Full Text] [Related]
5. [New psychopharmacologic studies on methadone: implications for the treatment of opiate dependency].
Eap CB
Rev Med Suisse Romande; 2000 Feb; 120(2):111-6. PubMed ID: 10748696
[TBL] [Abstract][Full Text] [Related]
6. Correlation between high methadone doses and methadone serum levels in methadone maintenance treatment (MMT) patients.
Adelson M; Peles E; Bodner G; Kreek MJ
J Addict Dis; 2007; 26(1):15-26. PubMed ID: 17439864
[TBL] [Abstract][Full Text] [Related]
7. Plasma concentrations of the enantiomers of methadone and therapeutic response in methadone maintenance treatment.
Eap CB; Bourquin M; Martin J; Spagnoli J; Livoti S; Powell K; Baumann P; Déglon J
Drug Alcohol Depend; 2000 Dec; 61(1):47-54. PubMed ID: 11064183
[TBL] [Abstract][Full Text] [Related]
8. Impact of blended treatment literacy and psychoeducation on methadone maintenance treatment outcomes in Yunnan, China.
Zhang B; Cai T; Yan Z; Mburu G; Wang B; Yang L
Harm Reduct J; 2016 Feb; 13():8. PubMed ID: 26915361
[TBL] [Abstract][Full Text] [Related]
9. Methadone maintenance.
Stancliff S
Am Fam Physician; 2001 Jun; 63(12):2335-6. PubMed ID: 11430450
[No Abstract] [Full Text] [Related]
10. Methadone maintenance for opioid dependence.
Kelly C
JAMA; 2000 Aug; 284(6):694-5. PubMed ID: 10927772
[No Abstract] [Full Text] [Related]
11. Methadone maintenance treatment: the need to distinguish between holding dose, dose adequacy, satisfaction with methadone as a medication, and satisfaction with treatment.
Trujols J; Siñol N; de los Cobos JP
J Clin Psychopharmacol; 2010 Feb; 30(1):95-6; author reply 96. PubMed ID: 20075667
[No Abstract] [Full Text] [Related]
12. Metabolism of methadone and levo-alpha-acetylmethadol (LAAM) by human intestinal cytochrome P450 3A4 (CYP3A4): potential contribution of intestinal metabolism to presystemic clearance and bioactivation.
Oda Y; Kharasch ED
J Pharmacol Exp Ther; 2001 Sep; 298(3):1021-32. PubMed ID: 11504799
[TBL] [Abstract][Full Text] [Related]
13. Moderate- vs high-dose methadone for opioid dependence.
Levinson D
JAMA; 1999 Dec; 282(22):2122; author reply 2122-3. PubMed ID: 10591330
[No Abstract] [Full Text] [Related]
14. Moderate- vs high-dose methadone for opioid dependence.
Grabowski J; Creson D; Rhoades HM; Schmitz JM
JAMA; 1999 Dec; 282(22):2121-2; author reply 2122-3. PubMed ID: 10591329
[No Abstract] [Full Text] [Related]
15. Enantiomeric metabolic interactions and stereoselective human methadone metabolism.
Totah RA; Allen KE; Sheffels P; Whittington D; Kharasch ED
J Pharmacol Exp Ther; 2007 Apr; 321(1):389-99. PubMed ID: 17259447
[TBL] [Abstract][Full Text] [Related]
16. New formulation of methadone for opioid dependence in France: acceptability and diversion/misuse liability.
Eiden C; Léglise Y; Bertomeu L; Clavel V; Faillie JL; Petit P; Peyrière H
Therapie; 2013; 68(2):107-11. PubMed ID: 23773351
[TBL] [Abstract][Full Text] [Related]
17. Methadone treatment.
Askey AW
CMAJ; 1999 Nov; 161(10):1241. PubMed ID: 10584083
[No Abstract] [Full Text] [Related]
18. Moderate- vs high-dose methadone for opioid dependence.
Newman RG
JAMA; 1999 Dec; 282(22):2122; author reply 2122-3. PubMed ID: 10591331
[No Abstract] [Full Text] [Related]
19. A discordance between cytochrome P450 2D6 genotype and phenotype in patients undergoing methadone maintenance treatment.
Shiran MR; Chowdry J; Rostami-Hodjegan A; Ellis SW; Lennard MS; Iqbal MZ; Lagundoye O; Seivewright N; Tucker GT
Br J Clin Pharmacol; 2003 Aug; 56(2):220-4. PubMed ID: 12895196
[TBL] [Abstract][Full Text] [Related]
20. Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity.
Mouly S; Bloch V; Peoc'h K; Houze P; Labat L; Ksouda K; Simoneau G; Declèves X; Bergmann JF; Scherrmann JM; Laplanche JL; Lepine JP; Vorspan F
Br J Clin Pharmacol; 2015 Jun; 79(6):967-77. PubMed ID: 25556837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
